| Wade Gaeddert, | |
|
2101 N Waldron St, Hutchinson, KS 67502-1131 | |
| (620) 669-2500 | |
| (620) 694-4180 |
| Full Name | Wade Gaeddert |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2101 N Waldron St, Hutchinson, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912977661 | NPI | - | NPPES |
| 100318680 B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 04-27850 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wade Gaeddert, 2101 N Waldron St, Hutchinson, KS 67502-1131 Ph: (620) 669-2500 | Wade Gaeddert, 2101 N Waldron St, Hutchinson, KS 67502-1131 Ph: (620) 669-2500 |
News Archive
A new commentary, published as an ‘In-Press Preview' in the Journal of Clinical Investigation, addresses the salient issue of vaccination against the coronavirus disease (COVID-19) in pregnancy and potential antibody transfer to the fetus – and provides the evidence in support of messenger RNA (mRNA) vaccine safety and efficacy for both maternal and child health.
Presented today at the International Osteoporosis Foundation's (IOF) Worldwide Conference of Osteoporosis Patient Societies in Beijing, the 2009 IOF-AMGEN Health Professional Awareness Grants aim to support innovative and cost effective projects by IOF member societies that focus on improving knowledge and raising awareness of osteoporosis among clinicians and allied health professionals.
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the U.S. Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD).
Canadian researchers have discovered a novel molecular mechanism that prevents cancer. In the December 11 edition of the prestigious journal Molecular Cell, scientists from the Universit- de Montr-al and the Universit- de Sherbrooke explain how they found that the SOCS1 molecule prevents the cancer-causing activity of cytokines, hormones that are culprits in cancer-prone chronic inflammation diseases such as Crohns, in smokers and people exposed to asbestos.
Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has received CE Mark Certification to commercially release its line of Endoskeleton® lumbar interbody fusion devices in Europe.
› Verified 5 days ago
Robert Epp, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-694-2170 | |
Carlos Garcia, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 | |
Dr. Matthew Scott Voorman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 |